Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma:: a study from the Groupe d'Etude des Lymphomes Folliculaires

被引:22
作者
Canioni, D
Brice, P
Lepage, E
Chababi, M
Meignin, V
Salles, B
Xerri, L
Péaud, PY
Rousselot, P
Peuchmaur, M
Solal-Céligny, P
Brousse, N
机构
[1] Hop Necker Enfants Malad, Dept Pathol, F-75743 Paris 15, France
[2] Hop St Louis, Inst Hematol, Paris, France
[3] Hop Henri Mondor, Biostat & Med Informat Dept, F-94010 Creteil, France
[4] Hop Chalon, Inst Med, Chalon Sur Saone, France
[5] Inst J Paoli I Calmettes, Dept Pathol, F-13009 Marseille, France
[6] Hop Valence, Dept Hematol, Valence, France
[7] Hop Robert Debre, Dept Pathol, F-75019 Paris, France
[8] Ctr Jean Bernard, Dept Hematol, Le Mans, France
[9] Hop St Louis, GELF, Paris, France
关键词
bone marrow pathology; follicular lymphoma; prognosis; statistical analysis;
D O I
10.1111/j.1365-2141.2004.05046.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of bone marrow biopsy (BMB) histology on prognosis and management of follicular lymphomas (FL) remains controversial. A total of 390 patients with grade 1 or 2 FL were prospectively included in the multicentric Groupe d'Etude des Lymphomes Folliculaires trial and their BMB reviewed in order (i) to quantify the ratio of lymphomatous foci (LFo) area to that of BMB size (LFo/BMB), (ii) to determine the BMB patterns for a practical grading of marrow infiltration, (iii) to assess the intra- and inter-observer reproducibility of this grading and (iv) to analyse this grading on event-free (EFS) and overall survival (OS), using univariate and multivariate analyses. A total of 267 patients (68%) had BMB involvement, with inter- and intra-observer reproducibility for classifying the patterns of involvement of 91 and 96%, respectively. Uni- and multivariate analyses demonstrated the adverse influence of (i) a ratio of LFo/BMB greater than or equal to0.1, i.e. three or four nodules/medullary space or greater than or equal to1 nodule + foci of diffuse involvement on EFS (P = 0.03) and (ii) two different histological patterns in the same BMB on EFS (P = 0.004) and OS (P = 0.001). This latter finding was only significant in patients with a high tumour burden and remained significant in multivariate analysis. These results indicate that BMB histology can predict survival of FL patients with a high tumour burden, and may help in defining their treatment.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 27 条
  • [21] McKenna RW, 1992, NEOPLASTIC HEMATOPAT
  • [22] NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT, AND BONE-MARROW BIOPSY ON STAGING AND MANAGEMENT
    POND, GD
    CASTELLINO, RA
    HORNING, S
    HOPPE, RT
    [J]. RADIOLOGY, 1989, 170 (01) : 159 - 164
  • [23] MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN STAGE-IV FOLLICULAR LOW-GRADE LYMPHOMA - A RISK MODEL
    ROMAGUERA, JE
    MCLAUGHLIN, P
    NORTH, L
    DIXON, D
    SILVERMINTZ, KB
    GARNSEY, LA
    VELASQUEZ, WS
    HAGEMEISTER, FB
    CABANILLAS, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) : 762 - 769
  • [24] ROSENBERG SA, 1982, CANCER, V49, P2112
  • [25] Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas:: Final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 trial
    Solal-Céligny, P
    Lepage, E
    Brousse, N
    Tendler, CL
    Brice, P
    Haïoun, C
    Gabarre, J
    Pignon, B
    Tertian, G
    Bouabdallah, R
    Rossi, JF
    Doyen, C
    Coiffier, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2332 - 2338
  • [26] RECOMBINANT INTERFERON-ALFA-2B COMBINED WITH A REGIMEN CONTAINING DOXORUBICIN IN PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
    SOLALCELIGNY, P
    LEPAGE, E
    BROUSSE, N
    REYES, F
    HAIOUN, C
    LEPORRIER, M
    PEUCHMAUR, M
    BOSLY, A
    PARLIER, Y
    BRICE, P
    COIFFIER, B
    GISSELBRECHT, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (22) : 1608 - 1614
  • [27] Follicular pattern of bone marrow involvement by follicular lymphoma
    Torlakovic, E
    Torlakovic, G
    Brunning, RD
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (05) : 780 - 786